JPRN-UMIN000048035
Not Yet Recruiting
N/A
Development of a method for identification of people at high risk of ulcerative colitis by analysis of a large residential cohort. - Method for determining risk of ulcerative colitis
Conditionslcerative Colitis
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- lcerative Colitis
- Sponsor
- Tohoku University
- Enrollment
- 200
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Cases who declined to participate in this study (opt\-out cases) (2\) Cases in which the principal investigator determines that the subject is inappropriate for the study (e.g., cases with a large number of missing data and cases in which analysis is extremely difficult) (3\) Cases in which the patient is found to have already died (4\) Cases in which the subject is a withdrawer of consent for a cohort study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 3
Development of the method for the identification of treatment resistance using hypoxia PETJPRN-UMIN000029884kyushu University100
Recruiting
Phase 2
A new method to detect air leakage using indocyanine green aerosolJPRN-jRCTs061190021Yokota Naoya200
Active, Not Recruiting
Phase 1
Development of an algorithm for identification of responders to short term treatment with esomeprazol (Nexium) in primary care. - PPI Response Trialacid related diseaseEUCTR2006-000574-69-DKAstraZeneca A/S
Not Yet Recruiting
N/A
Standardization of tool to identify cognitive declineHealth Condition 1: F028- Dementia in other diseases classified elsewhereCTRI/2024/01/061120Dr Nithya P R
Not Yet Recruiting
N/A
A study to measure the Peg-Asparaginase (a chemotherapy medicine) drug levels in the body and observe and record allergies after its use in children receiving treatment for acute lymphoblastic leukemia (a type of blood cancer).Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]CTRI/2024/03/063700Dr Chetan Dhamne